Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda
| dc.contributor.author | Nasuuna, Esther | |
| dc.contributor.author | Tenforde, Mark . W | |
| dc.contributor.author | Muganzi, Alex | |
| dc.contributor.author | Kigozi, Joanita | |
| dc.date.accessioned | 2024-10-13T19:20:15Z | |
| dc.date.available | 2024-10-13T19:20:15Z | |
| dc.date.issued | 2020-05-05 | |
| dc.description.abstract | Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of “Treat All” in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically. | |
| dc.identifier.citation | Esther Nasuuna, Mark W Tenforde, Alex Muganzi, Joseph N Jarvis, Yukari C Manabe, Joanita Kigozi, Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda, Clinical Infectious Diseases, Volume 71, Issue 9, 1 November 2020, Pages 2497–2499, https://doi.org/10.1093/cid/ciaa261 | |
| dc.identifier.issn | 1537-6591 | |
| dc.identifier.other | https://doi.org/10.1093/cid/ciaa261 | |
| dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/9650 | |
| dc.language.iso | en | |
| dc.publisher | Clinical Infectious Diseases | |
| dc.relation.ispartofseries | Volume 71; Issue 9 | |
| dc.title | Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda |